Plasma IL-18 and IL-18BP are altered differently in reverse remodeling following aortic valve replacement

Scand Cardiovasc J. 2010 Apr;44(2):113-8. doi: 10.3109/14017430903426902.

Abstract

Objectives: Patients with aortic stenosis (AS) develop left ventricular remodeling characterized by changes in extracellular matrix (ECM) and cardiomyocyte-hypertrophy. Aortic valve replacement (AVR) reverses this process (reverse remodeling). We examined plasma levels of interleukin-18 (IL-18) and its binding protein (IL-18BP) before and after AVR for AS since these mediators have been shown experimentally to exert effects on myocardial remodeling.

Design: Plasma levels of IL-18 and IL-18BP were analyzed in 22 patients with AS undergoing AVR, preoperatively, two days, six and 12 months postoperatively. Echocardiography and functional testing were performed.

Results: IL-18BP was significantly increased by 28% and 15% at two days and six months after AVR, compared to preoperative values. In contrast, IL-18 showed a later peak (increased by 24% at 12 months postoperatively) when IL-18BP was normalized. IL-18 correlated positively with deceleration time (R = 0.44) at this time-point which might indicate an association with diastolic function.

Conclusions: We report for the first time that plasma IL-18 and IL-18BP are differentially regulated after AVR for AS with an early increase in IL-18BP postoperatively followed by a later peak in IL-18 at 12 months. Given the known effects of these mediators on myocardial remodeling and function, they might play a role in the reverse and remodeling process associated with AVR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aortic Valve / surgery*
  • Aortic Valve Stenosis / immunology
  • Aortic Valve Stenosis / physiopathology
  • Aortic Valve Stenosis / surgery*
  • Biomarkers / blood
  • Bioprosthesis
  • Case-Control Studies
  • Echocardiography, Doppler, Color
  • Exercise Test
  • Female
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation* / instrumentation
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / physiopathology*
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Interleukin-18 / blood*
  • Male
  • Prospective Studies
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Up-Regulation
  • Ventricular Function, Left*
  • Ventricular Remodeling*

Substances

  • Biomarkers
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-18
  • interleukin-18 binding protein